Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosint is an Italian chemical-pharmaceutical manufacturing company focused on active pharmaceutical ingredients and nutraceutical ingredients for human and veterinary use. Founded in 1979, the company operates the Sermoneta production site and is part of the Alfasigma Group. Biosint manufactures pharmacologically active raw materials and provides custom manufacturing services, with particular expertise in carnitine chemistry, salts, and derivatives used as APIs and nutraceutical ingredients. The company serves domestic and international markets and operates to GMP-quality standards. Its business appears centered on commercial manufacturing rather than proprietary therapeutic drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosint.